SunBio,Inc. (KOSDAQ:067370)

South Korea · Delayed Price · Currency is KRW

6,090.00

-120.00 (-1.93%)

At close: Sep 3, 2026

Market Cap	73.41B -9.1%
Revenue (ttm)	2.17B +2.3%
Net Income	1.39B
EPS	249.33
Shares Out	12.19M
PE Ratio	24.14
Forward PE	n/a
Dividend	75.00 (1.21%)
Ex-Dividend Date	n/a

Volume	4,800
Open	6,220.00
Previous Close	6,210.00
Day's Range	6,040.00 - 6,220.00
52-Week Range	4,840.00 - 8,500.00
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SunBio,Inc.

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee. Its preclinical stage biopharmaceuticals candidates target brain stroke and chronic anemia. It also manufactures and sells PEG derivatives... [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1997

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 067370

Full Company Profile